Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants

Abstract Background We assessed the prognostic value of serological humoral markers measured one month after the last dose of the primary COVID-19 vaccine course for predicting the risk of severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 infection over the following six months in specific...

詳細記述

書誌詳細

主要な著者:	Mathieu Chalouni, Paul Loubet, Edouard Lhomme, Laetitia Ninove, Benoit Barrou, Jean-Yves Blay, Maryvonne Hourmant, Jérome de Seze, Martine Laville, Bruno Laviolle, Jean-Daniel Lelièvre, Jacques Morel, Stéphanie Nguyen Quoc, Jean-Philippe Spano, Benjamin Terrier, Anne Thiebaut, Jean-Francois Viallard, François Vrtovsnik, Sophie Circosta, Aude Barquin, Mariam Gharib, Eric Tartour, Béatrice Parfait, Rodolphe Thiébaut, Laurence Meyer, Xavier de Lamballerie, Odile Launay, Linda Wittkop, for the ANRS0001S COV-POPART study group
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2024-09-01
シリーズ:	BMC Infectious Diseases
主題:	Specific populations SARS-CoV-2 Vaccine Prediction
オンライン･アクセス:	https://doi.org/10.1186/s12879-024-09861-5
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!